Internal surgical staplers made headline news in 2019. Reports discussed the little-known US Food and Drug Administration database housing tens of thousands of stapler-related problem reports and covered the agency’s recent proposal to reclassify staplers as Class II devices, instead of the more lightly regulated Class I.
Growth is the goal in any ASC—growth in volume, growth…
Editor’s Note: This page is a companion piece to the…
Burnout continues to threaten the perioperative workforce, pushing many leaders…